[Event Report] HGPI-The University of Tokyo Joint Lecture “One Health, One Planet – Combating AMR for a Sustainable Future” (June 24, 2025)
date : 6/30/2025
Tags: AMR
Health and Global Policy Institute (HGPI) and AMR Alliance Japan together with the Department of Global Health Policy (GHP) at The University of Tokyo, co-hosted a joint lecture titled “One Health, One Planet – Combating AMR for a Sustainable Future: Understanding the Interconnections Between Human Health, Animal Health, Environment, and Sustainable Solutions.”
Dr. Kristina Osbjer, Director of Science at the International Centre for Antimicrobial Resistance Solutions (ICARS), delivered an insightful lecture that deepened interdisciplinary understanding of antimicrobial resistance (AMR) and emphasized the urgent need for multisectoral collaboration to combat AMR within the broader context of One Health recognizing the interdependence of human, animal, and environmental health.
The lecture explored AMR from a planetary health perspective, highlighting how human health, food systems, the environment, and sustainability are closely interconnected, while also addressing how issues like the overuse of antibiotics in agriculture, pollution of water systems with pharmaceutical residues, and loss of biodiversity are contributing to the global rise in drug resistance. Drawing from over 15 years of experience in low- and middle-income countries (LMICs), Dr. Osbjer shared practical strategies for integrating scientific research with policy and local implementation efforts.
Participants were encouraged to reflect on the systemic drivers of AMR and the need for coordinated, cross-disciplinary action noting that tackling AMR is not solely a clinical issue but a global public good challenge that intersects with climate change, sustainable development, and health equity. Participants left with new insights, strengthened networks, and a shared sense of urgency to advance collaborative solutions in their respective fields.
[Overview]
- Date & Time: Tuesday, June 24, 2025; 15:00-16:30 JST
- Format: In-Person
- Venue: The University of Tokyo (Hongo Campus), Faculty of Medicine Experimental Research Building, 13th floor, Seminar Room 6, #1304A (7-3-1 Hongo, Bunkyo-ku, Tokyo)
- Language: English (No interpretation)
- Participation Fee: Free
- Organized by: Health and Global Policy Institute (HGPI)
AMR Alliance Japan
Department of Global Health Policy (GHP), Graduate School of Medicine, The University of Tokyo (UTokyo) - In Collaboration with: International Center for Antimicrobial Resistance Solutions (ICARS)
[Program] (Titles omitted)
15:00-15:05 Welcome and Opening Remarks
Yui Kohno (Manager HGPI / AMR Alliance Japan)
15:05-15:35 Lecture “One Health and AMR: Perspectives from LMICs”
Kristina Osbjer (Director of Science, International Centre for Antimicrobial Resistance Solutions (ICARS))
15:35-16:00 Q&A Session
16:00-16:05 Closing Remarks
Vera Phung Ling Hui (Assistant Professor, Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo)
16:05-16:30 Networking
■ Speaker’s Profile
Kristina Osbjer (Director of Science, International Centre for Antimicrobial Resistance Solutions)
Dr. Kristina Osbjer is Director of Science at ICARS. She is a veterinary epidemiologist with over 15 years of working in research, capacity development and management of emerging health threats, including antimicrobial resistance, in low and middle-income countries. Kristina holds a degree in veterinary medicine (DVM) and a PhD in One Health and zoonotic diseases from the Swedish University of Agricultural Sciences. In the past, she has served as Team Lead on AMR and animal health for FAO and has worked closely with governments and the Quadripartite on governance and control of AMR and infectious diseases. She has strong experience across Asian countries from postings in the region.
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



